Non-sedation Versus Sedation With a Daily Wake-up Trial in Critically Ill Patients Receiving Me-chanical Ventilation - Effects on Cognitive Function

March 14, 2019 updated by: Palle Toft

Substudy of the NONSEDA Trial (NCT01967680): Non-sedation Versus Sedation With a Daily Wake-up Trial in Critically Ill Patients Receiving Me-chanical Ventilation - Effects on Cognitive Function

Through many years, the standard care has been to use continuous sedation of critically ill patients during mechanical ventilation. However, preliminary randomised clinical trials indicate that it is beneficial to reduce the sedation level in these patients. The NONSEDA trial is an investigator-initiated, randomised, clinical, parallel-group, multinational, superiority trial designed to include 700 patients from at least six ICUs in Denmark, Norway and Sweden, comparing no sedation with sedation and a daily wake-up trial during mechanical ventilation. This is a substudy of the NONSEDA trial, concerning 250 patients included at trialsite Kolding, Denmark. The aim of the substudy is to assess the effects of no sedation on delirium during admission and cognitive function after discharge from ICU.

Our hypothesis is that critically ill patients who are not sedated during mechanical ventilation will have better cognitive function after discharge.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

205

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kolding, Denmark, 6000
        • Lillebaelt Hospital, Kolding, Intensive Care Unit

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Endotracheally intubated
  • Expected time on ventilator > 24 hours
  • Age ≥ 18 years
  • Informed consent

Exclusion Criteria:

  • Severe head trauma where therapeutic coma is indicated
  • Therapeutic hypothermia where therapeutic coma is indicated
  • Status epilepticus where therapeutic coma is indicated
  • Patient has participated in the study before
  • Patient is transferred from another ICU with length of stay > 48 hours
  • Patient is comatose at admission
  • PaO2/FiO2 ≤ 9, if sedation is necessary for oxygenation
  • Patient does not speak Danish, swedish or norwegian at a reasonable level

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Non-sedation
Non-sedation supplemented with pain management during mechanical ventilation.
Patients are awake or have natural sleep during mechanical ventilation. Pain is treated with morphine iv.
ACTIVE_COMPARATOR: Sedation
Current gold standard: Sedation with a daily wake-up trial.
Continuous iv-sedation (propofol first 48 hours, from then midazolam) to Ramsey 3-4 with a daily wake up attempt, where sedation is stopped until patient is awake.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cognitive function
Time Frame: 3 months after discharge from ICU

Cognitive t-score, in percentage, difference between the two groups. The t-score for each patient will be diagnosed by the neuropsycologist at a personal interview and use of following tests:

  • Span of numbers
  • Coding test
  • Trailmaking A+B
  • Rey auditory verbal learning test (immediate, recall)
  • Rey-Ostherrieth complex figure test (immediate, recall, recognition)
  • Word finding test (S-word, animals)
  • Stroop test (congruent+incongruent)
3 months after discharge from ICU

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Attention/concentration
Time Frame: 3 months after discharge from ICU
T-score in the two groups for the cognitive domaine attention/concentration
3 months after discharge from ICU
Learning/memory
Time Frame: 3 months after discharge from ICU
t-score in the two groups for the cognitive domaine: learning/memory
3 months after discharge from ICU
Executive dysfunction
Time Frame: 3 months after discharge from ICU
t-score in the two groups for the cognitive domaine: executive dysfunction
3 months after discharge from ICU
Mental pace
Time Frame: 3 months after discharge from ICU
t-score in the two groups for the cognitive domaine: mental pace
3 months after discharge from ICU
Hypoactive delirium
Time Frame: 3 months after discharge from ICU
Occurrence of hypoactive delirium (RASS ≤ 0, CAM-ICU positive) in each group related to cognitive function at follow up
3 months after discharge from ICU
Agitated delirium
Time Frame: 3 months after discharge from ICU
Occurrence of agitated delirium (RASS ≥ +2, CAM-ICU positive) in each group related to cognitive function at follow up
3 months after discharge from ICU

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Helene Joergensen, MD, Lillebaelt Hospital, Kolding

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 1, 2014

Primary Completion (ACTUAL)

June 1, 2017

Study Completion (ACTUAL)

March 1, 2019

Study Registration Dates

First Submitted

January 10, 2014

First Submitted That Met QC Criteria

January 13, 2014

First Posted (ESTIMATE)

January 14, 2014

Study Record Updates

Last Update Posted (ACTUAL)

March 15, 2019

Last Update Submitted That Met QC Criteria

March 14, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • S-20130025c

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Delirium

Clinical Trials on Non-sedation

3
Subscribe